TUBGCP5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.207200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.733000E-01
Normal-vs-Stage2
3.451200E-01
Normal-vs-Stage3
1.385430E-01
Normal-vs-Stage4
5.658800E-01
Stage1-vs-Stage2
5.024000E-02
Stage1-vs-Stage3
7.168300E-02
Stage1-vs-Stage4
3.443000E-01
Stage2-vs-Stage3
2.151200E-01
Stage2-vs-Stage4
8.710600E-01
Stage3-vs-Stage4
1.714420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.644000E-01
Normal-vs-AfricanAmerican
4.683400E-01
Normal-vs-Asian
1.828190E-01
Caucasian-vs-AfricanAmerican
8.088600E-01
Caucasian-vs-Asian
5.411900E-02
AfricanAmerican-vs-Asian
3.449600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.678600E-01
Normal-vs-Female
6.401400E-01
Male-vs-Female
3.227800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.722800E-01
Normal-vs-Age(41-60Yrs)
5.302400E-01
Normal-vs-Age(61-80Yrs)
3.777200E-01
Normal-vs-Age(81-100Yrs)
4.002800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.547000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.458400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.190600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.644630E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.432400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.513600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.744600E-01
Normal-vs-Daily Drinker
2.387800E-01
Normal-vs-Weekly Drinker
4.359400E-01
Normal-vs-Occasional Drinker
4.494600E-01
Normal-vs-Social Drinker
7.496800E-01
Non Drinker-vs-Daily Drinker
9.864800E-01
Non Drinker-vs-Weekly Drinker
8.552800E-01
Non Drinker-vs-Occasional Drinker
3.471000E-01
Non Drinker-vs-Social Drinker
2.005600E-01
Daily Drinker-vs-Weekly Drinker
8.658000E-01
Daily Drinker-vs-Occasional Drinker
3.400000E-01
Daily Drinker-vs-Social Drinker
2.075600E-01
Weekly Drinker-vs-Occasional Drinker
5.788400E-01
Weekly Drinker-vs-Social Drinker
4.071000E-01
Occasional Drinker-vs-Social Drinker
6.226800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.086200E-02
Normal-vs-Grade 2
1.124140E-02
Normal-vs-Grade 3
1.186100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.641000E-01
Grade 1-vs-Grade 3
4.949000E-01
Grade 1-vs-Grade 4
7.086200E-02
Grade 2-vs-Grade 3
1.305180E-01
Grade 2-vs-Grade 4
1.124140E-02
Grade 3-vs-Grade 4
1.186100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.841950E-01
Normal-vs-NonDiabetic
4.254400E-01
Diabetic-vs-NonDiabetic
1.406250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.220000E-01
Normal-vs-NoPancreatitis
3.912400E-01
Pancreatitis-vs-NoPancreatitis
7.393600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.405600E-01
Normal-vs-N1
3.659200E-01
N0-vs-N1
3.920000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.948600E-01
Normal-vs-TP53-NonMutant
8.385800E-01
TP53-Mutant-vs-TP53-NonMutant
6.600600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
